Your browser doesn't support javascript.
loading
Early-Onset Parkinsonism Is a Manifestation of the PPP2R5D p.E200K Mutation.
Kim, Christine Y; Wirth, Thomas; Hubsch, Cécile; Németh, Andrea H; Okur, Volkan; Anheim, Mathieu; Drouot, Nathalie; Tranchant, Christine; Rudolf, Gabrielle; Chelly, Jamel; Tatton-Brown, Katrina; Blauwendraat, Cornelis; Vonsattel, Jean Paul G; Cortes, Etty; Alcalay, Roy N; Chung, Wendy K.
Afiliação
  • Kim CY; Department of Neurology, Yale School of Medicine, Yale University, New Haven, CT, USA.
  • Wirth T; Center for Neuroepidemiology and Clinical Neurological Research, Yale School of Medicine, Yale University, New Haven, CT, USA.
  • Hubsch C; Unit of Functional Neurosurgery, National Hospital for Neurology and Neurosurgery, University College London Hospital, London, UK.
  • Németh AH; Service de Neurologie, Hôpitaux Universitaires de Strasbourg, Strasbourg, France.
  • Okur V; Institut de Génétique et de Biologie Moléculaire et Cellulaire (IGBMC), INSERM-U964/CNRS-UMR7104/Université de Strasbourg, Illkirch-Graffenstaden, France.
  • Anheim M; Fondation Ophtalmologique A. de Rothschild, Paris, France.
  • Drouot N; Oxford University Hospitals NHS Trust and University of Oxford, Oxford, UK.
  • Tranchant C; Department of Pediatrics, College of Physicians and Surgeons, Columbia University, New York, NY, USA.
  • Rudolf G; Service de Neurologie, Hôpitaux Universitaires de Strasbourg, Strasbourg, France.
  • Chelly J; Institut de Génétique et de Biologie Moléculaire et Cellulaire (IGBMC), INSERM-U964/CNRS-UMR7104/Université de Strasbourg, Illkirch-Graffenstaden, France.
  • Tatton-Brown K; Fédération de Médecine Translationnelle de Strasbourg, Strasbourg, France.
  • Blauwendraat C; Institut de Génétique et de Biologie Moléculaire et Cellulaire (IGBMC), INSERM-U964/CNRS-UMR7104/Université de Strasbourg, Illkirch-Graffenstaden, France.
  • Vonsattel JPG; Service de Neurologie, Hôpitaux Universitaires de Strasbourg, Strasbourg, France.
  • Cortes E; Institut de Génétique et de Biologie Moléculaire et Cellulaire (IGBMC), INSERM-U964/CNRS-UMR7104/Université de Strasbourg, Illkirch-Graffenstaden, France.
  • Alcalay RN; Fédération de Médecine Translationnelle de Strasbourg, Strasbourg, France.
  • Chung WK; Service de Neurologie, Hôpitaux Universitaires de Strasbourg, Strasbourg, France.
Ann Neurol ; 88(5): 1028-1033, 2020 11.
Article em En | MEDLINE | ID: mdl-32743835
ABSTRACT
PPP2R5D-related neurodevelopmental disorder is characterized by a range of neurodevelopmental and behavioral manifestations. We report the association of early-onset parkinsonism with the PPP2R5D p.E200K mutation. Clinical characterization and exome sequencing were performed on three patients, with postmortem neuropathologic examination for one patient. All patients had mild developmental delay and developed levodopa-responsive parkinsonism between the ages of 25 and 40 years. The PPP2R5D c.598G>A (p.E200K) mutation was identified in all patients. Neuropathologic examination demonstrated uneven, focally severe neuronal loss and gliosis in the substantia nigra pars compacta, without Lewy bodies. Our findings suggest the PPP2R5D p.E200K mutation to be a possible new cause of early-onset parkinsonism. ANN NEUROL 2020;881028-1033.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Transtornos Parkinsonianos / Proteína Fosfatase 2 Tipo de estudo: Prognostic_studies Limite: Adult / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Transtornos Parkinsonianos / Proteína Fosfatase 2 Tipo de estudo: Prognostic_studies Limite: Adult / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2020 Tipo de documento: Article